Category Archives: Pr Newswire

Conference Call to Begin Today at 9:00 a.m. (ET) 2Q 2024 Total revenues of $72M; +49% vs. 2Q 2023 YTD 2024 Total revenues of $139M; +55% vs. YTD 2023 YTD 2024 Net income of $9 million; Non-GAAP net income of $29 million Advances two orphan lung programs to human studies MNKD-101 Phase 3 clinical trial […]

SAN FRANCISCO, Aug. 07, 2024 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the appointment of Francis Sarena as Chief Operating Officer, effective August 5, 2024. “We are excited to welcome Francis to […]

SANTA CLARA, Calif., Aug. 7, 2024 /PRNewswire/ — Tuya Inc. (“Tuya” or the “Company”) (NYSE: TUYA; HKEX: 2391), a global leading cloud platform service provider, today announced that it will report its second quarter 2024 unaudited financial results after the market closes on Monday, August 26, 2024. Tuya’s management will hold a conference call at 08:30 […]

GUELPH, ON, Aug. 7, 2024 /PRNewswire/ — Canadian Solar Inc. (the “Company” or “Canadian Solar”) (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company’s majority-owned subsidiary CSI Solar Co., Ltd. (“CSI Solar”), has been awarded a turnkey EPC contract for 100 MW / 200 MWh energy storage solutions by Fotowatio Renewable Ventures […]

Engagement is part of I-Mab’s commitment to transition to a U.S.-based biotech PwC to serve as independent registered public accounting firm for FY 2024 ROCKVILLE, Md., Aug. 7, 2024 /PRNewswire/ — I-Mab (NASDAQ: IMAB) (“I-Mab”, the “Company”), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the […]

CoE will cater to customers across mobility, high-tech, and sustainability segments TROY, Mich., and BANGALORE, India, Aug. 7, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, and L&T Technology Services (BSE: 540115, NSE: LTTS), a global digital engineering and R&D services company, jointly announced the establishment of a digital twin center of […]

CHENGDU, China, Aug. 7, 2024 /PRNewswire/ — The abilities of an electric garbage truck have become the talk of the town in Jizzakh, Uzbekistan. Capable of traveling 300 kilometers on a single charge and with a capacity of three metric tons in a streamlined design that allows easy navigation through narrow streets, the innovative vehicle was […]

– Agios Expects to Receive $905 Million Payment from Royalty Pharma and $200 Million Payment from Servier in Q3 2024; Payments Increase Agios’ Pro-Forma Cash Position as of June 30, 2024, to $1.7 Billion – – Strong Cash Position to Enable Agios to Prepare for Potential PYRUKYND® (Mitapivat) Launches in Thalassemia in 2025 and Sickle […]

TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announces that the Company’s name has been changed […]

Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance range Second Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) million Updates FY 2024 guidance GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2024. […]